Dyspepsia laboratory findings: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(11 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Dyspepsia}}
{{Dyspepsia}}
{{CMG}}
{{CMG}} {{AE}} {{Ajay}}
 
==Overview==
There is no specific diagnostic laboratory test for dyspepsia but in the patient with the history of dyspepsia, the laboratory test is used to rule out [[peptic ulcer]] [[bleeding]] and to document the status of eradication therapy (in terms of treatment failure or success), and to test refractory [[ulcers]].


==Laboratory Findings==
==Laboratory Findings==
People without risk factors for serious causes of dyspepsia usually do not need investigation beyond an office based clinical examination.  However, people over the age 55 years and those with alarm features are usually investigated by esophagogastroduodenoscopy (EGD or OGD in Britain). In this painless investigation the esophagus, stomach and duodenum are examined through an endoscope passed down through the mouth. This will rule out peptic ulcer disease, medication related ulceration, malignancy and other rarer causes.
*People under the age of 55 years with no alarm features do not need [[esophagogastroduodenoscopy]] ([[EGD]]) but are considered for investigation for [[peptic ulcer disease]] caused by ''[[Helicobacter pylori]]'' [[infection]].  
 
*Investigation for ''[[Helicobacter Pylori|H.pylori]]'' [[infection]] is usually performed when there is a moderate to high [[prevalence]] of this [[infection]] in the local community or the person with dyspepsia has other [[risk factors]] for ''[[H. pylori]]'' [[infection]], related for example to ethnicity or emigration from a high-[[prevalence]] area.  
People under the age of 55 years with no alarm features do not need EGD but are considered for investigation for peptic ulcer disease caused by ''[[Helicobacter pylori]]'' [[infection]]. Investigation for ''H.pylori'' infection is usually performed when there is a moderate to high prevalence of this infection in the local community or the person with dyspepsia has other risk factors for ''H. pylori'' infection, related for example to ethnicity or immigration from a high-prevalence area. If infection is confirmed it can usually be eradicated by medication.
*If the [[infection]] is confirmed it can usually be eradicated by medication.


Medication related dyspepsia is usually related to [[non-steroidal anti-inflammatory drug|Non-Steroidal Anti-inflammatory Drugs (NSAIDs)]]  and can be complicated by bleeding or ulceration with perforation of the stomach wall.
==Initial Laboratory Studies==
*There are no abnormal laboratory findings associated with dyspepsia.
*If there is the history of dyspepsia then following laboratory test are done:<ref name="pmid10086037">{{cite journal |vauthors=Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE |title=Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis |journal=Postgrad Med |volume=105 |issue=3 |pages=113–6, 121–3, 127–8 passim |year=1999 |pmid=10086037 |doi=10.3810/pgm.1999.03.594 |url=}}</ref><ref name="pmid2216988">{{cite journal |vauthors=Rosen SD, Rogers AI |title=Clinical recognition and evaluation of peptic ulcer disease |journal=Postgrad Med |volume=88 |issue=5 |pages=42–7,51,55 |year=1990 |pmid=2216988 |doi= |url=}}</ref><ref name="pmid25955624">{{cite journal |vauthors=Fashner J, Gitu AC |title=Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection |journal=Am Fam Physician |volume=91 |issue=4 |pages=236–42 |year=2015 |pmid=25955624 |doi= |url=}}</ref><ref name="pmid100860372">{{cite journal |vauthors=Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE |title=Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis |journal=Postgrad Med |volume=105 |issue=3 |pages=113–6, 121–3, 127–8 passim |year=1999 |pmid=10086037 |doi=10.3810/pgm.1999.03.594 |url=}}</ref><ref name="pmid26354049">{{cite journal |vauthors=Chung CS, Chiang TH, Lee YC |title=A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers |journal=Korean J. Intern. Med. |volume=30 |issue=5 |pages=559–70 |year=2015 |pmid=26354049 |pmc=4578017 |doi=10.3904/kjim.2015.30.5.559 |url=}}</ref><ref name="pmid21263414">{{cite journal |vauthors=Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K |title=Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors |journal=Med Glas (Zenica) |volume=8 |issue=1 |pages=151–7 |year=2011 |pmid=21263414 |doi= |url=}}</ref>
**[[Complete blood count]]
**[[Liver function tests]]
**Serum [[lipase]] and [[amylase]]
**[[Iron]] studies
**Some patients with dyspepsia may have reduced serum [[ferritin]], which is usually suggestive of [[bleeding]] which requires further [[endoscopy]] to rule out [[bleeding]]
'''Patient with a family history of peptic ulcer or there is history of refractory ulcer to treatment''' :
*A fasting serum [[gastrin]] level can be done to screen for [[Zollinger-Ellison syndrome]]
*If the diagnosis of Zollinger-Ellison syndrome cannot be made on the basis of the serum gastrin level, then next step is to do the [[secretin]] stimulation test
'''Following test can be done to document the residual infection after eradication therapy''':<ref name="pmid23551920">{{cite journal |vauthors=Korkmaz H, Kesli R, Karabagli P, Terzi Y |title=Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection |journal=Helicobacter |volume=18 |issue=5 |pages=384–91 |year=2013 |pmid=23551920 |doi=10.1111/hel.12053 |url=}}</ref><ref name="pmid11922552">{{cite journal |vauthors=Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F |title=Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy |journal=Am. J. Gastroenterol. |volume=97 |issue=3 |pages=594–9 |year=2002 |pmid=11922552 |doi=10.1111/j.1572-0241.2002.05535.x |url=}}</ref><ref name="pmid21264478">{{cite journal |vauthors=Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S |title=Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection |journal=J. Gastroenterol. |volume=46 |issue=4 |pages=487–91 |year=2011 |pmid=21264478 |doi=10.1007/s00535-011-0371-4 |url=}}</ref><ref name="pmid16091438">{{cite journal |vauthors=Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B |title=Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy |journal=J. Med. Microbiol. |volume=54 |issue=Pt 9 |pages=863–6 |year=2005 |pmid=16091438 |doi=10.1099/jmm.0.45914-0 |url=}}</ref><ref name="pmid15545164">{{cite journal |vauthors=Asfeldt AM, Løchen ML, Straume B, Steigen SE, Florholmen J, Goll R, Nestegard O, Paulssen EJ |title=Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection |journal=Scand. J. Gastroenterol. |volume=39 |issue=11 |pages=1073–7 |year=2004 |pmid=15545164 |doi=10.1080/00365520410007944 |url=}}</ref>
*[[Urea breath test]] (carbon 13) tests: This is used to document eradication therapy  and should be performed four to six weeks after completion of eradication therapy
**[[Urea breath test]] require the ingestion of [[urea]] labeled with the nonradioactive isotope carbon 13 or carbon 14
**[[Proton pump inhibitor|Proton pump inhibitors]] ([[Proton pump inhibitor|PPIs]]) should be stopped for two weeks before the test 
*Stool monoclonal antigen tests-This detect  active [[infection]] and can be used as a test of cure
**[[Proton pump inhibitor|PPIs]] should be stopped for two weeks before testing
**This can be done by following methods:
***[[Enzyme immunoassay]]
***Immunochromatography
***[[Antibody tests]]


==References==
==References==


{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Digestive disease symptoms]]
[[Category:Symptoms]]
[[Category:Needs patient information]]
[[Category:Signs and symptoms]]
[[Category:primary care]]

Latest revision as of 21:30, 29 July 2020

Dyspepsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dyspepsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dyspepsia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dyspepsia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dyspepsia laboratory findings

CDC on Dyspepsia laboratory findings

Dyspepsia laboratory findings in the news

Blogs on Dyspepsia laboratory findings

Directions to Hospitals Treating Dyspepsia

Risk calculators and risk factors for Dyspepsia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ajay Gade MD[2]]

Overview

There is no specific diagnostic laboratory test for dyspepsia but in the patient with the history of dyspepsia, the laboratory test is used to rule out peptic ulcer bleeding and to document the status of eradication therapy (in terms of treatment failure or success), and to test refractory ulcers.

Laboratory Findings

Initial Laboratory Studies

Patient with a family history of peptic ulcer or there is history of refractory ulcer to treatment :

  • A fasting serum gastrin level can be done to screen for Zollinger-Ellison syndrome
  • If the diagnosis of Zollinger-Ellison syndrome cannot be made on the basis of the serum gastrin level, then next step is to do the secretin stimulation test

Following test can be done to document the residual infection after eradication therapy:[7][8][9][10][11]

  • Urea breath test (carbon 13) tests: This is used to document eradication therapy and should be performed four to six weeks after completion of eradication therapy
  • Stool monoclonal antigen tests-This detect active infection and can be used as a test of cure

References

  1. Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE (1999). "Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis". Postgrad Med. 105 (3): 113–6, 121–3, 127–8 passim. doi:10.3810/pgm.1999.03.594. PMID 10086037.
  2. Rosen SD, Rogers AI (1990). "Clinical recognition and evaluation of peptic ulcer disease". Postgrad Med. 88 (5): 42–7, 51, 55. PMID 2216988.
  3. Fashner J, Gitu AC (2015). "Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection". Am Fam Physician. 91 (4): 236–42. PMID 25955624.
  4. Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE (1999). "Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis". Postgrad Med. 105 (3): 113–6, 121–3, 127–8 passim. doi:10.3810/pgm.1999.03.594. PMID 10086037.
  5. Chung CS, Chiang TH, Lee YC (2015). "A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers". Korean J. Intern. Med. 30 (5): 559–70. doi:10.3904/kjim.2015.30.5.559. PMC 4578017. PMID 26354049.
  6. Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K (2011). "Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors". Med Glas (Zenica). 8 (1): 151–7. PMID 21263414.
  7. Korkmaz H, Kesli R, Karabagli P, Terzi Y (2013). "Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection". Helicobacter. 18 (5): 384–91. doi:10.1111/hel.12053. PMID 23551920.
  8. Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F (2002). "Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy". Am. J. Gastroenterol. 97 (3): 594–9. doi:10.1111/j.1572-0241.2002.05535.x. PMID 11922552.
  9. Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S (2011). "Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection". J. Gastroenterol. 46 (4): 487–91. doi:10.1007/s00535-011-0371-4. PMID 21264478.
  10. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B (2005). "Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy". J. Med. Microbiol. 54 (Pt 9): 863–6. doi:10.1099/jmm.0.45914-0. PMID 16091438.
  11. Asfeldt AM, Løchen ML, Straume B, Steigen SE, Florholmen J, Goll R, Nestegard O, Paulssen EJ (2004). "Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection". Scand. J. Gastroenterol. 39 (11): 1073–7. doi:10.1080/00365520410007944. PMID 15545164.

Template:WH Template:WS